Nuveen’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-10,000
Closed -$1.21M 1424
2016
Q2
$1.21M Buy
+10,000
New +$1.14M 0.01% 951
2016
Q1
Sell
-5,000
Closed -$514 1453
2015
Q4
$514 Sell
5,000
-6,000
-55% -$603K ﹤0.01% 1273
2015
Q3
$1.03K Hold
11,000
0.01% 1075
2015
Q2
$1.07K Sell
11,000
-10,000
-48% -$1M 0.01% 1129
2015
Q1
$2.11M Sell
21,000
-52,000
-71% -$5.29M 0.01% 821
2014
Q4
$7.63M Buy
73,000
+1,000
+1% +$105K 0.04% 452
2014
Q3
$7.67M Hold
72,000
0.05% 429
2014
Q2
$7.53M Buy
72,000
+2,000
+3% +$202K 0.05% 440
2014
Q1
$6.88M Sell
70,000
-35,000
-33% -$3.24M 0.04% 439
2013
Q4
$9.62M Sell
105,000
-18,000
-15% -$1.66M 0.06% 365
2013
Q3
$12.1M Sell
123,000
-34,000
-22% -$3.05M 0.08% 319
2013
Q2
$13.5M Buy
+157,000
New +$13.3M 0.09% 289

Other funds holding JNJ

Nuveen's JNJ Position: Q1 2026 in Review

Nuveen increased its Johnson & Johnson (JNJ) stake by 18% in Q1 2026, buying an estimated $438M and bringing the position to 12,490,455 shares worth $3.05B. The position accounts for 0.83% of the portfolio, ranked #16.

Nuveen first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,621 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Nuveen held 12,490,455 shares of Johnson & Johnson worth $3.05B as of Q1 2026.
  • Nuveen bought 1,881,284 Johnson & Johnson shares in Q1 2026, an estimated $438M.
  • Johnson & Johnson made up 0.83% of Nuveen's portfolio in Q1 2026, its #16 holding.
  • Nuveen first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,621 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.